Latest filing published 01 Aug 2012 for HUMAN GENOME SCIENCES INC, €29k.
No signal scores available.
This profile gathers the share dealings of Allan Baxter in Human Genome Sciences Inc. Over a trading history stretching from 17 May 2012 to 30 July 2012, the count stands at 2 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 1 August 2012, the filings show a transaction worth €29k in Human Genome Sciences Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations